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Table S1. Elution Program for the Silica Gel Column Separation 
n-hexane 100 95 90 88 85 82 80 77 74 71 67 
EtOAc 0 5 10 12 15 18 20 23 26 29 33 
V (ml) 200 700 700 400 200 700 400 500 700 800 700 
Fr. No. - - - - - 0-46 47-62 63-82 83-113 114-148 149-182 
 
n-hexane 63 60 57 54 50 40 30 20 0 
EtOAc 37 40 43 46 50 60 70 80 100 
V (ml) 400 700 700 400 300 300 200 200 200 
Fr. No. 183-200 201-229 230-260 261-277 278-290 291-305 306-315 316-330 331-339 
 
 Figure S1. Aromatic part of the 1H NMR spectrum of compound 1 
 
 
Figure S2. Aliphatic part of the 1H NMR spectrum of compound 1 
 Figure S3. Aromatic part of the 13C NMR spectrum of compound 1 
 
Figure S4. Aliphatic part of the 13C NMR spectrum of compound 1 
 Figure S5. Aromatic part of the COSY spectrum of compound 1 
 
Figure S6. The first part of the NOESY spectrum of compound 1 
 Figure S7. The second part of the NOESY spectrum of compound 1 
 
Figure S8. The third part of the NOESY spectrum of compound 1 
 Figure S9. Aromatic part of the HSQC spectrum of compound 1 
 
Figure S10. Aliphatic part of the HSQC spectrum of compound 1 
 Figure S11. The first part of the HMBC spectrum of compound 1 
 
Figure S12. The second part of the HMBC spectrum of compound 1 
  
Figure S13. Aromatic part of the 1H NMR spectrum of compound 2 
 
Figure S14. Aliphatic part of the 1H NMR spectrum of compound 2 
 Figure S15. Aromatic part of the 13C NMR spectrum of compound 2 
 
Figure S16. Aliphatic part of the 13C NMR spectrum of compound 2 
 Figure S17. Aromatic part of the COSY spectrum of compound 2 
 
Figure S18. The first part of the NOESY spectrum of compound 2 
 Figure S19. The second part of the NOESY spectrum of compound 2 
 
Figure S20. The third part of the NOESY spectrum of compound 2 
 Figure S21. Aromatic part of the HSQC spectrum of compound 2 
 
Figure S22. The first part of the HMBC spectrum of compound 2 
 Figure S23. The second part of the HMBC spectrum of compound 2 
 
Figure S24. The third part of the HMBC spectrum of compound 2 
 Figure S25. Aromatic part of the 1H NMR spectrum of compound 3 
 
 
Figure S26. Aliphatic part of the 1H NMR spectrum of compound 3 
  
Figure S27. Aromatic part of the 13C NMR spectrum of compound 3 
 
 
Figure S28. Aliphatic part of the 13C NMR spectrum of compound 3 
 Figure S29. Aromatic part of the COSY spectrum of compound 3 
 
Figure S30. Aromatic part of the NOESY spectrum of compound 3 
 Figure S31. Aromatic part of the HSQC spectrum of compound 3 
 
Figure S32. The first part of the HMBC spectrum of compound 3 
 Figure S33. The second part of the HMBC spectrum of compound 3 
 
Figure S34. The third part of the HMBC spectrum of compound 3 
 Figure S35. Aromatic part of the 1H NMR spectrum of compound 4 
 
 
Figure S36. Aliphatic part of the 1H NMR spectrum of compound 4 
 Figure S37. Aromatic part of the 13C NMR spectrum of compound 4 
 
 
Figure S38. Aliphatic part of the 13C NMR spectrum of compound 4 
 Figure S39. Aromatic part of the COSY spectrum of compound 4 
 
Figure S40. The first part of the NOESY spectrum of compound 4 
 Figure S41. Aromatic part of the HSQC spectrum of compound 4 
 
Figure S42. Aliphatic part of the HSQC spectrum of compound 4 
 Figure S43. Aromatic part of the HMBC spectrum of compound 4 
 
 
Figure S44. Aromatic part of the 1H NMR spectrum of riccardin F at room temperature 
 
 Figure S45. Aromatic part of 1H NMR spectrum of the purified riccardin F at 243K 
 
 
Figure S46. Aromatic part of the 1H NMR spectrum of compound 5 recorded in CD3OD 
 Figure S47. Aliphatic part of the 1H NMR spectrum of compound 5 recorded in CD3OD 
 
Figure S48. Aromatic part of the 1H NMR spectrum of compound 5 recorded in mixture of 
CDCl3 and CD3OD 
 Figure S49. Aromatic part of the 13C NMR spectrum of compound 5 recorded in mixture of 
CDCl3 and CD3OD 
 
Figure S50. Aromatic part of the COSY spectrum of compound 11 recorded in mixture of 
CDCl3 and CD3OD 
 Figure S51. NOE correlations of aromatic protons of compound 5 
 
Figure S52. HSQC correlations of aromatic protons of compound 5 
 Figure S53. HSQC correlations of aliphatic protons of compound 5 
 
Figure S54. The first part of the HMBC spectrum of compound 5 recorded in mixture of 
CDCl3 and CD3OD 
 
  
 
Figure S55. The second part of the HMBC spectrum of compound 5 recorded in mixture of 
CDCl3 and CD3OD 
 
Figure S56. HMBC correlations of benzyl protons of compound 5  
 Figure S57. Aromatic part of the 1H NMR spectrum of compound 6 
Figure S58. Aliphatic part of the 1H NMR spectrum of compound 6 
 Figure S59. Aromatic part of the 13C NMR spectrum of compound 6 
 
Figure S60. Aliphatic part of the 13C NMR spectrum of compound 6 
 Figure S61. Aromatic part of the COSY spectrum of compound 6 
 
Figure S62. The first part of the NOESY spectrum of compound 6 
 Figure S63. The second part of the NOESY spectrum of compound 6 
 
Figure S64. Aromatic part of the HSQC spectrum of compound 6 
 Figure S65. Aliphatic part of the HSQC spectrum of compound 6 
 
Figure S66. The first part of the HMBC spectrum of compound 6 
 Figure S67. The second part of the HMBC spectrum of compound 6 
 
 
Figure S68. Aromatic part of the 1H NMR spectrum of compound 7 
 Figure S69. Aliphatic part of the 1H NMR spectrum of compound 7 
 
Figure S70. Aromatic part of the 13C NMR spectrum of compound 7 
 Figure S71. Aliphatic part of the 13C NMR spectrum of compound 7 
 
Figure S72. Aromatic part of the COSY spectrum of compound 7 
 Figure S73. Aromatic part of the NOESY spectrum of compound 7 
 
Figure S74. Aromatic part of the HSQC spectrum of compound 7 
 Figure S75. Aliphatic part of the HSQC spectrum of compound 7 
 
 
Figure S76. The first part of the HMBC spectrum of compound 7 
 Figure S77. The second part of the HMBC spectrum of compound 7 
 
Figure S78. The third part of the HMBC spectrum of compound 7 
 Figure S79. HMBC correlation H-8/C-10 in compound 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Cytotoxicity (IC50, µM) of Bisbibenzyls on Two Human Cell Lines Determined by MTT 
Assay 
 Cell line SI 
Compound MRC5 A549  
Lunularin 200 150  
Perrottetin E 40.0 25.0  
Perrottetin F 30.0 15.0  
Riccardin C 15.0 22.5  
Riccardin F 15.0 30.0  
Riccardin G 7.5 2.5 3 
1 40.0 10.0 4 
2 60.0 10.0 6 
3 5.0 5.0 1 
4 15.0 10.0 1.5 
5 3.0 5.0 0.6 
6 30.0 60.0  
7 15.0 40.0  
Methylated 
perrottetin E 
>120b >120  
Methylated 
Perrottetin F 
>120 >120  
Cisplatin 3.5 2.5 1.4 
a Results represent mean of three independant experiments  
done in quadriplicate, with standard deviation between 1-5%. 
b not cytotoxic under tested conditions. 
cSI – selectivity index 
 
